Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000038

Director acquired 1,389 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anderson Kenneth Carl · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-04-01 Grant or award : show line 1 in the form +1,389 $8.10 $11,251 112,351 D
Loading xslF345X05/wk-form4_1712090101.xml…